Artificial Intelligence

HYCU earns its sixth straight CRN 5-Star award, signaling market dominance through its partner-first strategy and expansive R-Cloud SaaS support.

As AI reshapes medicine, Seoul prepares to host global experts to explore its vast potential and critical challenges in healthcare and medical tourism.

OneSpan finalizes its acquisition of Build38, integrating AI-driven defenses to combat a new generation of sophisticated mobile and financial threats.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

With a $41M boost from a16z, Ease Health is using AI to unify a fractured behavioral health system, promising relief for overwhelmed providers.

Following a chaotic power outage, unions and city leaders rally against Waymo, demanding answers on public safety, job security, and regulatory oversight.

With 175 million lenses implanted, Alcon solidifies its market leadership. Discover the technology giving patients unprecedented freedom from glasses.

After a dramatic pivot and massive fundraising, Galecto will detail its new hematology pipeline at a key conference. Here’s what investors are watching.

Amid soaring uranium prices, Refined Energy begins its maiden drill program in Saskatchewan's prolific Athabasca Basin, a high-stakes bet on nuclear's future.

With a $6B M&A war chest and a new AI focus, Roper Technologies takes the stage at Morgan Stanley. Here’s what investors will be watching for.

In a strategic reverse merger with Rallybio, T-cell therapy innovator Candid Therapeutics secures over $505M to advance its groundbreaking autoimmune pipeline.

A new era in hearing arrives with Cochlear's Nexa System, the world's first upgradeable implant, tackling India's vast auditory health challenges.

As Middle East conflict roiled markets, 24/7 on-chain gold offered an immediate safe haven, challenging the dominance of traditional financial systems.

With major trials underway for its cancer and vision drugs, NovaBridge's upcoming investor presentation could be a pivotal moment for the biotech firm.

Zoetis is acquiring Neogen's genomics unit for $160M, a strategic move set to accelerate data-driven innovation in livestock and companion animal care.

Asia's largest pharma show returns, showcasing China's evolution from the world's factory to a global hub of drug innovation and supply chain strategy.

With a strong cash position and promising drug candidate, Apogee Therapeutics is advancing multiple trials to challenge the I&I market with a new therapy.

Amid soaring cyber-attack costs in Asia, cloud security firm Upwind is tripling its workforce and deploying local infrastructure to deliver real-time protection.

The healthcare firm reports a 56% revenue surge to $3.2B, but a "material weakness" in financial controls and a delayed SEC filing cast a shadow.

At MODEX 2026, KNAPP will unveil its AI-driven 'Brain' and award-winning 3D robots, promising a new era of intelligent, adaptive supply chains.